Q&A: Meet David Nutt, the Professor Who Ranked Every Drug by Societal Harm — and Put Alcohol First

Named by the Evening Standard as one of the top 100 people shaping London in 2025, Professor David Nutt has authored over 500 research papers and more than 30 books. One of the world’s foremost ...
Celine Tran on MSN

Vet school expectations vs pharmacology reality

I filmed this after a long stretch of vet school pharmacology, when I realized how different my excitement for vet med was from actually memorizing endless drug charts. The video starts with me ...

Intracellular signaling proteins emerge as a key target in drug development

In a recently published review, a research team led by MedUni Vienna has highlighted a promising new approach to drug discovery. The focus is on the targeted modulation of certain intracellular ...
The Times of Israel on MSN

Israeli researchers find cannabis compounds could lead to 1st drug for fatty liver disease

As 1 out of every 3 adults worldwide suffers from the condition, Hebrew University scientists use non-psychoactive substances ...
The Lancet

The boom in counterfeit obesity drugs

Driven by high prices, lack of insurance, and a desire to lose weight, the proliferation of fake and falsified obesity drugs is prompting public health concern. Sophie Cousins reports.

Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA™ and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development

Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime is the ...
Psychology Today

Carfentanil Was an Elephant Sedative. Now It's a Human Drug Problem

Once used by vets to anesthetize elephants, carfentanil is now an extremely dangerous illicit drug often disguised as an oxycodone tablet—and it's 100 times stronger than fentanyl.

Could popular weight loss drugs become the new treatment for addiction? Evidence is starting to mount

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...
FierceBiotech

Denali's Hunter syndrome drug latest to be hit by FDA decision delay

Denali Therapeutics has become the latest on a growing list of biotechs to experience an FDA review delay in recent months. The agency in July accepted an application for Denali's enzyme replacement ...
The Conversation

Calling in the animal drug detectives − helping veterinarians help beluga whales, goats and all creatures big and small

Sherry Cox does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...
Scientific Research Publishing

Personalized Medicine in Cardiovascular Pharmacology: Advances in Pharmacogenomics and Drug Development ()

1 Department of Medicine, Maitama District Hospital/Department of Medicine, College of Medicine, Baze University, Abuja, Nigeria. 2 Department of Human Physiology, College of Medicine and Health ...
C&EN

Design, Synthesis, and Biological Evaluation of Novel Hydroxyamidine Derivatives as Indoleamine 2,3-Dioxygenase 1 Inhibitors

Institute of Medicinal Biotechnology, Peking Union Medical College & Chinese Academy of Medical Sciences, Tian Tan Xi Li No.1, Beijing 100050, PR China Institute of Medicinal Biotechnology, Peking ...